Torrent Pharma eyes strategic US manufacturing, strengthens global growth plans
[ad_1] Ahmedabad-based Torrent Pharma, the flagship of the Torrent Group, is charting an ambitious growth path by focusing on innovation in chronic therapies and expanding into high-growth segments. The company, known for its Rs 500-crore vitamin brand Shelcal (including variants) and cardiac drug Nikoran with Rs 245-crore sales, plans to leverage its core strengths while…
